Ergoteles’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,337
Closed -$799K 1595
2022
Q4
$799K Sell
11,337
-40,826
-78% -$2.88M 0.03% 540
2022
Q3
$3.16M Buy
52,163
+42,509
+440% +$2.85M 0.11% 185
2022
Q2
$610K Buy
+9,654
New +$629K 0.02% 751
2021
Q4
Sell
-3,000
Closed -$214K 1476
2021
Q3
$214K Sell
3,000
-11,151
-79% -$880K 0.01% 954
2021
Q2
$1.15M Buy
+14,151
New +$1.14M 0.03% 466

Other funds holding NGVT

Ergoteles's NGVT Position: Q1 2023 in Review

Ergoteles sold out of Ingevity (NGVT) in Q1 2023, closing a stake of 11,337 shares — an estimated $799K sold.

Ergoteles first reported a position in NGVT in Q2 2021 and held it in 5 quarters. The position peaked at $3.16M in Q3 2022. 281 funds tracked by Wall St. Rank hold NGVT as of Q1 2023.

  • Ergoteles reported no remaining Ingevity position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 11,337 Ingevity shares in Q1 2023, an estimated $799K.
  • Ergoteles first reported a position in Ingevity in Q2 2021 and held it in 5 quarters.
  • Ergoteles's Ingevity position peaked at $3.16M in Q3 2022.
  • 281 funds tracked by Wall St. Rank held Ingevity as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.